The FDA has issued guidance about compounded GLP-1 medications during shortage periods, generally supporting their use when brand options are unavailable
Altering the prescribed dose schedule can reduce the medications effectiveness, slowing down expected weight loss results
Methods A non-systematic literature search was performed on PubMed using as search terms (acetyl-l-carnitine OR L-acetylcarnitine OR ALCAR) in conjunction with one of the following: nerve damage, neuropathy, peripheral neuropathy, radiculopathy, neuropathic pain, diabetic polyneuropathy, chemotherapy-induced polyneuropathy, carpal tunnel syndrome, Fabry disease
While ingredients like berberine have a different mechanism of action than common GLP-1 agonists, they can help naturally increase the secretion of this hormone for weight loss support
As with the disease itself, T2D economic models are complex